Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$64.69 - $85.07 $11,385 - $14,972
-176 Reduced 4.63%
3,629 $262,000
Q1 2022

May 12, 2022

SELL
$76.3 - $103.81 $38,607 - $52,527
-506 Reduced 11.74%
3,805 $315,000
Q4 2021

Feb 02, 2022

SELL
$92.98 - $124.15 $23,709 - $31,658
-255 Reduced 5.58%
4,311 $445,000
Q3 2021

Nov 12, 2021

SELL
$77.49 - $109.17 $550,566 - $775,652
-7,105 Reduced 60.88%
4,566 $467,000
Q2 2021

Aug 03, 2021

BUY
$86.59 - $107.47 $603,965 - $749,603
6,975 Added 148.53%
11,671 $1.11 Million
Q1 2021

May 10, 2021

SELL
$66.32 - $90.93 $94,837 - $130,029
-1,430 Reduced 23.34%
4,696 $383,000
Q4 2020

Feb 11, 2021

SELL
$46.7 - $75.22 $8,359 - $13,464
-179 Reduced 2.84%
6,126 $416,000
Q3 2020

Nov 13, 2020

SELL
$42.77 - $56.69 $937,732 - $1.24 Million
-21,925 Reduced 77.67%
6,305 $292,000
Q2 2020

Aug 11, 2020

BUY
$26.54 - $44.24 $15,260 - $25,438
575 Added 2.08%
28,230 $1.25 Million
Q1 2020

May 08, 2020

SELL
$22.69 - $44.14 $18,537 - $36,062
-817 Reduced 2.87%
27,655 $843,000
Q4 2019

Feb 07, 2020

BUY
$35.49 - $48.05 $5,323 - $7,207
150 Added 0.53%
28,472 $1.2 Million
Q3 2019

Oct 31, 2019

BUY
$30.18 - $41.75 $24,717 - $34,193
819 Added 2.98%
28,322 $1.05 Million
Q2 2019

Aug 09, 2019

SELL
$29.53 - $41.1 $1.33 Million - $1.85 Million
-45,067 Reduced 62.1%
27,503 $1.07 Million
Q1 2019

Apr 24, 2019

BUY
$24.38 - $33.75 $1.77 Million - $2.45 Million
72,570 New
72,570 $2.13 Million
Q3 2018

Oct 26, 2018

SELL
$28.71 - $39.6 $470,844 - $649,440
-16,400 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$24.88 - $36.36 $37,320 - $54,540
-1,500 Reduced 8.38%
16,400 $535,000
Q1 2018

May 01, 2018

BUY
$23.3 - $30.15 $417,070 - $539,685
17,900 New
17,900 $485,000

Others Institutions Holding AZTA

About Azenta, Inc.


  • Ticker AZTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 75,020,400
  • Market Cap $3.75B
  • Description
  • Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...
More about AZTA
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.